logo

Home

|

Products

|

9789356962026

Image of - Small Molecules in Hematology | Third Edition | Hardcover
Small Molecules in Hematology | Third Edition | Hardcover

Small Molecules in Hematology | Third Edition | Hardcover

by Martens

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title.

Highlights

  • binding-icon

    9783319914381

    ISBN

  • binding-icon

    Martens

    Author

  • binding-icon

    294

    Pages

  • binding-icon

    623 gm

    Weight

  • langauage-icon

    English

    Language

  • date-icon

    2018

    Year

  • edition-icon

    Third Edition

    Edition

  • binding-icon

    Hardcover

    Binding

10912

12125

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title.

Loading...

Online store of medical books

Discover a comprehensive range of medical books at our online store. From anatomy and physiology to the latest clinical guidelines, we've got you covered.

Trusted by students, educators, and healthcare professionals worldwide. Browse top publishers and expert-authored titles in every medical specialty. Enjoy fast shipping, secure payments, and easy returns. Your one-stop destination for quality medical knowledge at your fingertips.

Whether you're preparing for exams or expanding your clinical expertise, our curated collection ensures you have the right resources at hand. Dive into detailed illustrations, case studies, and up-to-date research that enhance your understanding and practical skills.

We regularly update our inventory to include the latest editions and newly released titles, helping you stay current in the ever-evolving medical field. Our advanced search and filtering tools make finding the perfect book quick and hassle-free.

Join our community of lifelong learners and medical enthusiasts. Sign up for exclusive discounts, early access to new arrivals, and personalized book recommendations tailored to your professional interests.